Literature DB >> 17275053

Isolation and propagation of Trypanosoma brucei gambiense from sleeping sickness patients in south Sudan.

Naomi W N Maina1, Michael Oberle, Charles Otieno, Christina Kunz, Pascal Maeser, Joseph M Ndung'u, Reto Brun.   

Abstract

This study aimed at isolating Trypanosoma brucei gambiense from human African trypanosomiasis (HAT) patients from south Sudan. Fifty HAT patients identified during active screening surveys were recruited, most of whom (49/50) were in second-stage disease. Blood and cerebrospinal fluid samples collected from the patients were cryopreserved using Triladyl as the cryomedium. The samples were stored at -150 degrees C in liquid nitrogen vapour in a dry shipper. Eighteen patient stabilates could be propagated in immunosuppressed Mastomys natalensis and/or SCID mice. Parasitaemia was highest in SCID mice. Further subpassages in M. natalensis increased the virulence of the trypanosomes and all 18 isolates recovered from M. natalensis or SCID mice became infective to other immunosuppressed mouse breeds. A comparison of immunosuppressed M. natalensis and Swiss White, C57/BL and BALB/c mice demonstrated that all rodent breeds were susceptible after the second subpassage and developed a parasitaemia >10(6)/ml by Day 5 post infection. The highest parasitaemias were achieved in C57/BL and BALB/c mice. These results indicate that propagation of T. b. gambiense isolates after initial isolation in immunosuppressed M. natalensis or SCID mice can be done in a range of immunosuppressed rodents.

Entities:  

Mesh:

Year:  2007        PMID: 17275053     DOI: 10.1016/j.trstmh.2006.11.008

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  12 in total

1.  Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.

Authors:  Tanja Wenzler; Sihyung Yang; Olivier Braissant; David W Boykin; Reto Brun; Michael Zhuo Wang
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

2.  Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood.

Authors:  Enock Matovu; Irene Kuepfer; Alex Boobo; Stafford Kibona; Christian Burri
Journal:  J Clin Microbiol       Date:  2010-04-21       Impact factor: 5.948

3.  A search for Trypanosoma brucei rhodesiense diagnostic antigens by proteomic screening and targeted cloning.

Authors:  Theresa Manful; Julius Mulindwa; Fernanda M Frank; Christine E Clayton; Enock Matovu
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

4.  Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice.

Authors:  Patient Pati Pyana; Ipos Ngay Lukusa; Dieudonné Mumba Ngoyi; Nick Van Reet; Marcel Kaiser; Stomy Karhemere Bin Shamamba; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2011-04-19

Review 5.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

6.  Luminescent multiplex viability assay for Trypanosoma brucei gambiense.

Authors:  Nick Van Reet; Pati Pyana; Stijn Rogé; Filip Claes; Philippe Büscher
Journal:  Parasit Vectors       Date:  2013-07-15       Impact factor: 3.876

7.  Kenya Trypanosomiasis Research Institute cryobank for human and animal trypanosome isolates to support research: opportunities and challenges.

Authors:  Grace A Murilla; Kariuki Ndung'u; John K Thuita; Purity K Gitonga; Daniel T Kahiga; Joanna E Auma; Johnson O Ouma; Jane J Rutto; Joseph M Ndung'u
Journal:  PLoS Negl Trop Dis       Date:  2014-05-22

8.  A panel of Trypanosoma brucei strains tagged with blue and red-shifted luciferases for bioluminescent imaging in murine infection models.

Authors:  Nick Van Reet; Hélène Van de Vyver; Patient Pati Pyana; Anne Marie Van der Linden; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

9.  Aquaglyceroporin-null trypanosomes display glycerol transport defects and respiratory-inhibitor sensitivity.

Authors:  Laura Jeacock; Nicola Baker; Natalie Wiedemar; Pascal Mäser; David Horn
Journal:  PLoS Pathog       Date:  2017-03-30       Impact factor: 6.823

10.  Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.

Authors:  Fabrice E Graf; Philipp Ludin; Tanja Wenzler; Marcel Kaiser; Reto Brun; Patient Pati Pyana; Philippe Büscher; Harry P de Koning; David Horn; Pascal Mäser
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.